Novartis (NVS) CEO Joe Jimenez says the company may make bolt-on purchases of $2-4B but doesn't "need a big acquisition in the short term." Novartis is looking to buy assets to offset patent expirations, with Jimenez saying the firm wants to expand its generics business with respiratory and dermatology treatments, and injectable cancer therapies. The company won't sell its loss-making vaccines ops or other smaller units.
Are you Bullish or Bearish on ?
Results for ()
Thanks for sharing your thoughts.
From other sites
at MarketWatch.com (Fri, 5:15PM)
at Zacks.com (Thu, 3:19PM)
at Nasdaq.com (Feb 27, 2015)
at Zacks.com (Feb 24, 2015)
at Investor's Business Daily (Feb 23, 2015)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs